tranylcypromine has been researched along with Anemia, Sickle Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, S; Engel, JD; Shi, L; Tanabe, O | 1 |
| DeSimone, J; Ibanez, V; Jagadeeswaran, R; Kouznetsova, T; Lavelle, D; Rivers, A; Ruiz, MA; Vaitkus, K | 1 |
2 other study(ies) available for tranylcypromine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction.
Topics: Anemia, Sickle Cell; Animals; beta-Globins; beta-Thalassemia; Cell Differentiation; Cells, Cultured; Erythroid Cells; Fetal Hemoglobin; gamma-Globins; Histone Demethylases; Humans; Mice; Mice, Transgenic; Molecular Targeted Therapy; Monoamine Oxidase Inhibitors; Nuclear Receptor Subfamily 2, Group C, Member 1; Promoter Regions, Genetic; Receptors, Steroid; Receptors, Thyroid Hormone; RNA Interference; RNA, Small Interfering; Tranylcypromine | 2013 |
RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model.
Topics: Anemia, Sickle Cell; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Inhibitors; Erythroid Precursor Cells; Erythropoiesis; Fetal Hemoglobin; gamma-Globins; Gene Expression Regulation; Hematopoietic Stem Cells; Histone Demethylases; Histones; Humans; Hydroxyurea; Methylation; Mice; Mice, Transgenic; Papio; Protein Processing, Post-Translational; Reticulocytes; Transgenes; Tranylcypromine; Tretinoin; U937 Cells | 2015 |